Agile Therapeutics Revenue 2013-2023 | AGRX
Agile Therapeutics revenue from 2013 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Agile Therapeutics Annual Revenue (Millions of US $) |
2023 |
$20 |
2022 |
$11 |
2021 |
$4 |
2020 |
$1 |
2019 |
$ |
2018 |
$ |
2017 |
$ |
2016 |
$ |
2015 |
$ |
2014 |
$ |
2013 |
$ |
2012 |
$ |
Agile Therapeutics Quarterly Revenue (Millions of US $) |
2023-12-31 |
$4 |
2023-09-30 |
$7 |
2023-06-30 |
$6 |
2023-03-31 |
$4 |
2022-12-31 |
$4 |
2022-09-30 |
$3 |
2022-06-30 |
$2 |
2022-03-31 |
$2 |
2021-12-31 |
$2 |
2021-09-30 |
$1 |
2021-06-30 |
$1 |
2021-03-31 |
$0 |
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
|
2018-06-30 |
|
2018-03-31 |
|
2017-12-31 |
|
2017-09-30 |
|
2017-06-30 |
|
2017-03-31 |
|
2016-12-31 |
|
2016-09-30 |
|
2016-06-30 |
|
2016-03-31 |
|
2015-12-31 |
|
2015-09-30 |
|
2015-06-30 |
|
2015-03-31 |
|
2014-12-31 |
|
2014-09-30 |
|
2014-06-30 |
|
2014-03-31 |
|
2013-12-31 |
|
2013-09-30 |
|
2013-06-30 |
|
2012-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|